BIODELIVERY SCIENCES INTL IN's ticker is BDSI and the CUSIP is 09060J106. A total of 120 filers reported holding BIODELIVERY SCIENCES INTL IN in Q3 2019. The put-call ratio across all filers is 0.24 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $2,861,000 | -73.8% | 755,000 | -70.9% | 3.03% | -71.5% |
| Q3 2019 | $10,929,000 | -15.0% | 2,595,855 | -6.1% | 10.61% | +19.8% |
| Q2 2019 | $12,855,000 | +57.6% | 2,764,475 | +79.6% | 8.85% | +88.6% |
| Q1 2019 | $8,159,000 | -44.6% | 1,539,437 | -61.3% | 4.69% | -63.7% |
| Q4 2018 | $14,733,000 | +22.1% | 3,981,867 | -7.6% | 12.94% | +83.3% |
| Q3 2018 | $12,071,000 | +175.3% | 4,311,103 | +190.1% | 7.06% | +164.9% |
| Q2 2018 | $4,384,000 | -47.4% | 1,486,002 | -59.9% | 2.66% | -40.4% |
| Q1 2018 | $8,339,000 | -22.5% | 3,706,084 | +1.7% | 4.47% | -30.7% |
| Q4 2017 | $10,754,000 | -5.7% | 3,645,491 | -5.7% | 6.44% | -4.2% |
| Q3 2017 | $11,409,000 | +17.2% | 3,867,400 | +11.2% | 6.72% | +27.9% |
| Q2 2017 | $9,737,000 | +80.1% | 3,477,673 | +22.2% | 5.26% | +72.6% |
| Q1 2017 | $5,405,000 | +18.8% | 2,844,820 | +9.4% | 3.05% | +12.4% |
| Q4 2016 | $4,551,000 | +16153.6% | 2,600,711 | +30414.0% | 2.71% | +8115.2% |
| Q1 2016 | $28,000 | – | 8,523 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 2,595,855 | $10,929,000 | 10.61% |
| Broadfin Capital, LLC | 4,300,066 | $18,103,000 | 3.35% |
| 1492 Capital Management LLC | 778,483 | $3,277,000 | 3.20% |
| Avoro Capital Advisors LLC | 7,424,867 | $31,259,000 | 1.30% |
| Rubric Capital Management LP | 2,590,288 | $10,905,000 | 1.00% |
| Eversept Partners, LP | 708,020 | $2,980,764 | 0.92% |
| KNOTT DAVID M | 517,507 | $2,179,000 | 0.92% |
| Nantahala Capital Management | 4,846,167 | $20,402,000 | 0.76% |
| Grandeur Peak Global Advisors, LLC | 1,180,075 | $4,968,000 | 0.54% |
| EMERALD ADVISERS, LLC | 2,084,685 | $8,777,000 | 0.41% |